A detailed history of Wealthspire Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 28,509 shares of BMY stock, worth $1.65 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
28,509
Previous 27,223 4.72%
Holding current value
$1.65 Million
Previous $1.13 Million 30.53%
% of portfolio
0.02%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $51,002 - $66,550
1,286 Added 4.72%
28,509 $1.48 Million
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $58,926 - $77,577
-1,464 Reduced 5.1%
27,223 $1.13 Million
Q1 2024

May 06, 2024

SELL
$47.98 - $54.4 $322,137 - $365,241
-6,714 Reduced 18.97%
28,687 $1.56 Million
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $289,037 - $344,901
5,962 Added 20.25%
35,401 $1.82 Million
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $282,387 - $315,752
4,878 Added 19.86%
29,439 $1.71 Million
Q2 2023

Jul 31, 2023

SELL
$63.71 - $70.74 $160,676 - $178,406
-2,522 Reduced 9.31%
24,561 $1.57 Million
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $288,992 - $327,782
-4,398 Reduced 13.97%
27,083 $1.88 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $247,966 - $293,626
3,621 Added 13.0%
31,481 $2.26 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $665 - $393,651
5,123 Added 22.53%
27,860 $1.98 Million
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $350,972 - $386,543
4,833 Added 26.99%
22,737 $1.75 Million
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $372,999 - $447,259
-6,067 Reduced 25.31%
17,904 $1.31 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $94,656 - $110,347
1,765 Added 7.95%
23,971 $1.5 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $955,713 - $1.12 Million
16,152 Added 266.8%
22,206 $1.31 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $2.12 Million - $2.31 Million
-34,236 Reduced 84.97%
6,054 $405,000
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $516,258 - $580,638
8,700 Added 27.54%
40,290 $2.54 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $582,538 - $660,123
10,089 Added 46.92%
31,590 $1.96 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $207,379 - $229,804
3,611 Added 20.18%
21,501 $1.3 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $1.01 Million - $1.19 Million
-18,515 Reduced 50.86%
17,890 $1.05 Million
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $1.26 Million - $1.83 Million
27,128 Added 292.42%
36,405 $2.03 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $214,555 - $279,868
4,360 Added 88.67%
9,277 $595,000
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $210,300 - $249,341
4,917 New
4,917 $249,000
Q1 2019

May 08, 2019

SELL
$45.12 - $53.8 $48,007 - $57,243
-1,064 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $51,880 - $67,276
1,064 New
1,064 $55,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wealthspire Advisors, LLC Portfolio

Follow Wealthspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.